NURS 6521 Advanced Pharmacology: Week-by-Week Assignment Guide, Discussion Posts, and Study Resources for Nurse Practitioner Students

Nurse practitioner students searching for NURS 6521 Advanced Pharmacology assignment help, discussion post examples, and weekly study guides will find that mastering pharmacotherapeutics across body systems requires both clinical reasoning and a firm grasp of prescriptive authority, drug interactions, and population-specific considerations.

Course Overview: NURS 6521 Advanced Pharmacology

NURS 6521: Advanced Pharmacology is a graduate-level nursing course that prepares advanced practice nurses to prescribe, monitor, and evaluate pharmacological treatments across the lifespan. The course draws heavily on Rosenthal and Burchum’s Lehne’s Pharmacotherapeutics for Advanced Practice Providers (2018) as its foundational text, supplementing each week with peer-reviewed journal articles, federal regulatory resources, and interactive media cases that simulate real clinical decision-making scenarios. Students are expected to integrate pharmacokinetics, pharmacodynamics, and ethical prescribing principles from the very first week, building a cumulative clinical knowledge base that feeds directly into midterm and final assessments.

Week-by-Week Resource and Assignment Breakdown

Week 1: Foundations of Prescriptive Authority and Safe Drug Therapy

Required readings begin with Chapters 1 through 6 of Rosenthal and Burchum (2018), covering prescriptive authority, rational drug selection, pharmacokinetics, pharmacodynamics, adverse drug reactions, and individual variation in drug response. These foundational chapters set the regulatory and scientific framework that informs every prescribing decision an advanced practice nurse will make throughout the course and in clinical practice. The American Geriatrics Society 2019 Updated AGS Beers Criteria is also assigned in Week 1, introducing students to the evidence-based list of potentially inappropriate medications for older adults, a resource that remains clinically indispensable for any NP working with geriatric populations.

Additional regulatory resources from the Drug Enforcement Administration cover the Code of Federal Regulations, mid-level practitioner prescribing authority by state, controlled substance schedules, and DEA registration requirements. Taken together, these readings ensure students understand not only the pharmacological science but also the legal boundaries within which they will prescribe. The Institute for Safe Medication Practices (ISMP) list of error-prone abbreviations is another assigned reference, reminding students that medication errors frequently originate at the prescription-writing stage rather than the dispensing stage.

Week 2: Cardiovascular Pharmacology

Week 2 moves into cardiovascular disorders, assigning Chapters 34 through 44, which cover diuretics, renin-angiotensin-aldosterone system agents, calcium channel blockers, vasodilators, antihypertensives, heart failure drugs, antidysrhythmics, lipid-lowering agents, antianginals, and anticoagulants. The required media for this week features Dr. Norbert Myslinski discussing the comparative profiles of ACE inhibitors, angiotensin receptor blockers, beta-blockers, calcium channel blockers, and diuretics in hypertension management, prompting students to think critically about which drug class best suits a given patient’s comorbidity profile. Students are expected to apply the Joint National Committee guidelines and current American Heart Association standards when framing their discussion responses about antihypertensive drug selection.

Week 3: Pulmonary Pharmacology and Asthma Management

Chapters 60 and 61 address respiratory pharmacology, focusing on drugs for asthma, chronic obstructive pulmonary disease, allergic rhinitis, cough, and colds. The National Heart, Lung, and Blood Institute’s Expert Panel Report 3 (EPR3) guidelines for asthma diagnosis and management are assigned as a supplemental web resource, providing age-specific treatment recommendations that students should cross-reference when completing any case-based assignments. An APA Presentation Template is also provided in Week 3, which signals that a formal presentation assignment is likely embedded in the module for this week or the following one.

Week 4: Gastrointestinal Pharmacology and Antiviral Agents

Week 4 covers Chapters 62 through 64 and Chapter 78, addressing peptic ulcer disease, laxatives, other gastrointestinal drugs, and non-HIV antiviral agents. The Chalasani et al. (2018) article on nonalcoholic fatty liver disease from Hepatology supplements the textbook by detailing both pathophysiology and current pharmacotherapeutic recommendations, which is particularly relevant as NAFLD prevalence continues to rise in the United States and represents a growing prescribing challenge for primary care NPs.

Week 5: Endocrine Pharmacology and the Midterm

Chapters 46 and 47 cover diabetes mellitus drugs and thyroid disorder agents, respectively. The American Diabetes Association’s 2018 standards of medical care in diabetes are assigned to provide pharmacologic guidance on glycemic control, and students should use this resource when constructing any discussion posts about insulin regimens, GLP-1 receptor agonists, or SGLT-2 inhibitors. Week 5 also includes the Mid-Term Summary and Study Guide, indicating that the summative midterm assessment occurs at or around this point in the semester.

Week 6: Neuropharmacology, Psychiatric Drugs, and Musculoskeletal Agents

Week 6 is among the most content-heavy weeks in the course, spanning Chapters 10 through 20 on nervous system pharmacology, Parkinson disease, Alzheimer disease, epilepsy, and muscle spasm, as well as Chapters 57 through 59 on rheumatoid arthritis, gout, and bone mineralization drugs. Two interactive media cases are assigned, covering Alzheimer’s disease prescribing decisions and complex regional pain disorder management, both of which ask students to simulate the clinical reasoning process before receiving feedback. The American Academy of Family Physicians’ dementia resource supplements the Alzheimer’s readings with patient education and complication management guidance.

Week 8: Psychopharmacology

Week 8 focuses on psychiatric pharmacotherapy, with Chapters 24 through 29 covering antipsychotics, antidepressants, bipolar disorder drugs, sedative-hypnotics, anxiolytics, and CNS stimulants for ADHD. Four interactive media files are assigned, addressing adult geriatric depression, ADHD, bipolar therapy, and generalized anxiety disorder, each requiring students to make prescribing decisions in simulated patient scenarios. Discussion posts for this week frequently ask students to compare first-generation and second-generation antipsychotics or to evaluate the risk-benefit profile of a specific antidepressant class for a patient with a co-occurring medical condition.

Week 9: Reproductive Pharmacology

Chapters 48 through 51 address estrogens, progestins, contraception, androgens, erectile dysfunction drugs, and benign prostatic hyperplasia agents. Two supplemental journal articles are assigned: Lunenfeld et al. (2015) on hypogonadism in men and Roberts and Hickey (2016) on menopause management, both of which reflect the evidence base students should cite in any reproductive pharmacology discussion posts. The Agency for Healthcare Research and Quality’s guide to clinical preventive services rounds out the week with population-level screening and preventive medication recommendations for adult patients.

Week 10: Anti-infective Pharmacology and Final Exam Preparation

Week 10 covers Chapters 68 through 80, addressing antimicrobial principles, penicillins, sulfonamides, urinary tract infection drugs, antimycobacterial agents, antifungals, antivirals, and sexually transmitted disease pharmacotherapy. The Montaner et al. (2014) article on HAART therapy and HIV treatment as prevention is assigned, documenting the population-level reductions in morbidity and mortality achieved through expanded antiretroviral coverage in British Columbia, a case study that reinforces the public health dimension of advanced pharmacology practice. The Final Exam Study Guide is also distributed during Week 10.

Week 11: Pediatric Pharmacology and Off-Label Prescribing

Chapter 8 addresses drug therapy in pediatric patients, and two journal articles are assigned: Corny et al. (2015) on unlicensed and off-label drug use in children before and after governmental initiatives, and Panther et al. (2017) on off-label prescribing trends for ADHD medications in very young children. Students are expected to analyze the ethical and regulatory tensions involved in prescribing to pediatric populations, where approved drug options are often limited and off-label use is both common and necessary. The interactive media file on therapy for pediatric clients with mood disorders closes out the course’s clinical simulation series.

Sample Discussion Post Response: NURS 6521 Pharmacology Case Study

Advanced pharmacology practice demands that NPs move beyond memorizing drug names and instead develop the clinical reasoning to match the right agent to the right patient at the right dose, accounting for age, organ function, comorbidities, and potential drug interactions simultaneously. In a case involving a 72-year-old patient with heart failure, type 2 diabetes, and stage 3 chronic kidney disease, for instance, the prescribing decision for glycemic control becomes considerably more constrained than it would be in a younger, renally intact patient; metformin carries FDA warnings at low estimated GFR thresholds, and several SGLT-2 inhibitors lose efficacy as kidney function declines (American Diabetes Association, 2018). The Beers Criteria assigned in Week 1 would further flag several sedative-hypnotics and first-generation antihistamines as potentially inappropriate in this patient, underscoring how population-specific guidelines actively shape prescribing choices in geriatric care. Selecting a GLP-1 receptor agonist with demonstrated cardiovascular benefit, such as liraglutide or semaglutide, may represent the most defensible choice in this scenario, provided renal dosing parameters and patient injection tolerance are both confirmed. Documenting the rationale for that selection, including the evidence consulted and alternatives considered, reflects the standard of rational drug selection outlined in Chapter 2 of Rosenthal and Burchum (2018).

The prescribing complexity illustrated in the case above reflects patterns documented across graduate nursing education research. Sabatino et al. (2017) found that pharmacist-led educational interventions significantly improved NP students’ prescribing skills and their perception of preparedness to prescribe, suggesting that simulation-based and interprofessional learning approaches are among the most effective ways to close the gap between pharmacological knowledge and clinical application. The ISMP continues to report that high-alert medications, including anticoagulants, insulin, and opioids, account for a disproportionate share of serious medication errors, which is precisely why NURS 6521 integrates error prevention resources alongside therapeutic content from the very first week. For NP students, building a habit of cross-referencing prescribing decisions against current guidelines, whether from the ADA, the American Heart Association, or the AGS Beers Criteria, is not an academic exercise but a patient safety practice that will carry forward into every clinical encounter.

 Peer-Reviewed References

• American Geriatrics Society 2019 Beers Criteria Update Expert Panel. (2019). American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), pp. 674–694. Available at: https://doi.org/10.1111/jgs.15767
• American Diabetes Association. (2018). Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes — 2018. Diabetes Care, 41(Supplement 1), pp. S73–S85. Available at: http://care.diabetesjournals.org/content/41/supplement_1/s73.full-text.pdf
• Rosenthal, L.D. and Burchum, J.R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
• Sabatino, J.A., Pruchnicki, M.C., Sevin, A.M., Barker, E., Green, C.G. and Porter, K. (2017). Improving prescribing practices: a pharmacist-led educational intervention for nurse practitioner students. Journal of the American Association of Nurse Practitioners, 29(5), pp. 248–254. Available at: https://doi.org/10.1002/2327-6924.12446
• Panther, S.G., Knotts, A.M., Odom-Maryon, T., Daratha, K., Woo, T. and Klein, T.A. (2017). Off-label prescribing trends for ADHD medications in very young children. The Journal of Pediatric Pharmacology and Therapeutics, 22(6), pp. 423–429. Available at: https://doi.org/10.5863/1551-6776-22.6.423

1. What are the weekly assignments and discussion topics for NURS 6521 Advanced Pharmacology at Walden University?
2. NURS 6521 Pharmacology Weekly Guide
3. NURS 6521 Advanced Pharmacology Week-by-Week Assignment Guide: Discussion Posts, Resources, and Study Tips for NP Students
4. Advanced Pharmacology NP Course Weekly Breakdown
5. When pharmacology meets clinical reasoning: a complete NURS 6521 study and assignment resource
6. Complete a week-by-week review of NURS 6521 Advanced Pharmacology assignments, discussion posts, and required readings in approximately 800–1,000 words per module, covering cardiovascular, endocrine, psychiatric, pediatric, and anti-infective pharmacotherapy for advanced practice nurses.
7. Navigate a full 11-week, resource-rich course guide for NURS 6521 Advanced Pharmacology, covering 2–3 pages of weekly reading summaries, discussion post examples, and prescribing case analyses aligned with Rosenthal and Burchum (2018).
8. Access weekly discussion post guidance, sample answers, and peer-reviewed references for NURS 6521 Advanced Pharmacology, covering prescriptive authority, drug interactions, and population-specific pharmacotherapy across the NP curriculum.

~~~~~

NURS 6521 Week 3 Assignment: Asthma and COPD Pharmacotherapy Presentation

Course: NURS 6521: Advanced Pharmacology

Prepare an APA-formatted presentation in which you analyze the pharmacotherapeutic management of a patient presenting with asthma or chronic obstructive pulmonary disease, drawing on the NHLBI EPR3 guidelines and Chapters 60 and 61 of Rosenthal and Burchum (2018). Your presentation should identify the patient’s current medication regimen, evaluate the appropriateness of each agent based on current evidence-based guidelines, and recommend any necessary adjustments with a clear rationale grounded in pharmacokinetics and pharmacodynamics. Include at least three peer-reviewed references published within the past five years, and apply the APA Presentation Template provided in the Week 3 resources to format your slides and reference list correctly. Your final submission should demonstrate the ability to integrate clinical guidelines, patient-specific variables, and prescribing safety considerations into a coherent pharmacological treatment plan.